Supplementary_Section_30Oct2018 – Supplemental material for Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study ...

• Main Authors: Bessette, Louis, Boulos Haraoui, Chow, Andrew, Fortin, Isabelle, Dixit, Sanjay, Khraishi, Majed, Haaland, Derek, Elmoufti, Sami, Staelens, Fabienne, Bogatyreva, Irina, Syrotuik, Jerry, Shaikh, Saeed
• Format: Text
• Language: unknown
• Published: SAGE Journals 2019
• Subjects: 110314 Orthopaedics; FOS: Clinical medicine; 110604 Sports Medicine; FOS: Health sciences; 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified; sami
• Online Access: https://dx.doi.org/10.25384/sage.7808048; https://sage.figshare.com/articles/Supplementary_Section_30Oct2018_Supplemental_material_for_Effectiveness_and_safety_of_certolizumab_pegol_in_rheumatoid_arthritis_patients_in_Canadian_practice_2-year_results_from_the_observational_F_sT-CAN_study/7808048

Supplemental material, Supplementary_Section_30Oct2018 for Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study by Louis Bessette, Boulos Haraoui, Andrew Chow, Isabelle Fortin, Sanjay Dixit, Majed Khraishi, Derek Haaland, Sami Elmoufti, Fabienne Staelens, Irina Bogatyreva, Jerry Syrotuik and Saeed Shaikh in Therapeutic Advances in Musculoskeletal Disease ...